Medicare Enrolled
Dr. Aleem Syed, MD
Endocrinology · Anaheim, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Syed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Syed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Syed
Dr. Aleem Syed is an endocrinology specialist in Anaheim, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Syed performed 2,536 Medicare services across 617 unique beneficiaries.
Between the years covered by Open Payments, Dr. Syed received a total of $13,341 from 64 pharmaceutical and/or device companies across 691 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Syed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in CA
$13,341 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,536
Medicare services
Top 26% in CA for endocrinology
617
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~133 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,367 | $66 | $125 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
539 | $41 | $105 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $98 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
148 | $99 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
126 | $145 | $299 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $69 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $125 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $109 | $253 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,341
Total received (2018-2024)
Avg $1,906/year across 7 years
Top 16% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
64
Companies
691
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,195 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$147 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,277
2023
$1,873
2022
$1,807
2021
$2,072
2020
$1,160
2019
$1,810
2018
$2,343
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$382
Lilly USA, LLC
$326
Abbott Laboratories
$177
Insulet Corporation
$177
Kyowa Kirin, Inc.
$177
RECORDATI_RARE_DISEASES_INC.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Antares Pharma, Inc.
$92
Medtronic, Inc.
$84
Xeris Pharmaceuticals, Inc.
$72
Ascendis Pharma Inc
$63
Dexcom, Inc.
$60
ABBVIE INC.
$43
Boston Scientific Corporation
$38
Novartis Pharmaceuticals Corporation
$33
Novo Nordisk Inc
$32
Mannkind Corporation
$31
CeQur Corporation
$29
Rhythm Pharmaceuticals, Inc.
$27
Neurocrine Biosciences, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$22
IBSA Pharma Inc.
$20
BETA BIONICS, INC.
$19
Alexion Pharmaceuticals, Inc.
$18
Amphastar Pharmaceuticals, Inc.
$18
TheracosBio, LLC
$16
Astellas Pharma US Inc
$14
Tolmar, Inc.
$14
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,969
Amgen Inc.
$1,045
Insulet Corporation
$929
SANOFI-AVENTIS U.S. LLC
$918
Novo Nordisk Inc
$840
Boehringer Ingelheim Pharmaceuticals, Inc.
$548
AstraZeneca Pharmaceuticals LP
$533
Abbott Laboratories
$456
Antares Pharma, Inc.
$355
Xeris Pharmaceuticals, Inc.
$343
Becton, Dickinson and Company
$330
Horizon Therapeutics plc
$321
Janssen Pharmaceuticals, Inc
$310
Corcept Therapeutics
$287
RECORDATI_RARE_DISEASES_INC.
$221
Merck Sharp & Dohme Corporation
$218
Kyowa Kirin, Inc.
$204
Amarin Pharma Inc.
$202
MannKind Corporation
$202
Medtronic, Inc.
$197
AbbVie, Inc.
$179
Bayer Healthcare Pharmaceuticals Inc.
$162
Medtronic MiniMed, Inc.
$151
Ipsen Biopharmaceuticals, Inc
$148
AbbVie Inc.
$139
Bigfoot Biomedical Inc
$133
Dexcom, Inc.
$132
Esperion Therapeutics, Inc.
$128
Tandem Diabetes Care, Inc.
$124
DEXCOM, INC.
$123
Astellas Pharma US Inc
$122
Novartis Pharmaceuticals Corporation
$111
CeQur Corporation
$108
Ultragenyx Pharmaceutical Inc.
$87
Bayer HealthCare Pharmaceuticals Inc.
$80
Zealand Pharma US, Inc.
$69
Mannkind Corporation
$69
Ascendis Pharma Inc
$63
IBSA Pharma Inc.
$59
ABBVIE INC.
$58
Valeritas, Inc.
$55
Merck Sharp & Dohme LLC
$47
PFIZER INC.
$45
Medtronic USA, Inc.
$42
Tolmar, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$39
Shire North American Group Inc
$38
Boston Scientific Corporation
$38
Averitas Pharma Inc.
$30
Rhythm Pharmaceuticals, Inc.
$27
Radius Health, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$25
Neurocrine Biosciences, Inc.
$22
Otsuka America Pharmaceutical, Inc.
$22
Amryt Pharma Holdings Ltd
$20
Acerus Pharmaceuticals Corporation
$20
BETA BIONICS, INC.
$19
Alexion Pharmaceuticals, Inc.
$18
Sun Pharmaceutical Industries Inc.
$18
Amphastar Pharmaceuticals, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
TheracosBio, LLC
$16
Shield Therapeutics Inc
$16
Amneal Pharmaceuticals LLC
$13
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFREZZA · AVYCAZ · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CRYSVITA · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EZALLOR SPRINKLE · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GUARDIAN SENSOR (3) · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · IMCIVREE · INCEPTIV · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · KAPSPARGO · Kerendia · Korlym · LEQVIO · LYRICA · Levemir · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · NATPARA · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · QUTENZA · RECORLEV · Repatha · Rybelsus · SAMSCA · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Skytrofa · Somatuline Depot · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · UPLIZNA · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VECTRIS · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
233
Per 100K population
7.4
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Syed is a mixed practice specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Syed experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Syed performed 1,367 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Syed receive payments from pharmaceutical companies?
Yes. Dr. Syed received a total of $13,341 from 64 companies across 691 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Syed's costs compare to other endocrinologists in Anaheim?
Dr. Syed's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Syed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Anaheim
Browse endocrinologists in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Insulet Corporation Payments to Doctors
See all physicians who received payments from Insulet Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology